Incorporation of water-insoluble anticancer drug into polymeric micelles and control of their particle size

Journal of Controlled Release

Volumn 55, Issue 2-3, 1998, Pages 219-229

  Yokoyama, Masayuki ^a,c   Satoh, Ayumi ^a   Sakurai, Yasuhisa ^a,c   Okano, Teruo ^a,c   Matsumura, Yasuhiro ^b   Kakizoe, Tadao ^b   Kataoka, Kazunori ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

^c TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Anticancer drug; Drug carrier; Drug targeting; Polymeric micelles; Solubility

Indexed keywords

6 [4 DEOXY 4 (2,4 TETRADECADIENOYLGLYCYLAMINO) GLYCERO BETA MANNOHEPTOPYRANOSYLAMINO] 9H PURINE; ANTINEOPLASTIC AGENT; COPOLYMER; DRUG CARRIER; MACROGOL; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DETERMINATION; DRUG DISTRIBUTION; MICELLE; NONHUMAN; PRIORITY JOURNAL; ULTRASOUND;

ANTIBIOTICS, ANTINEOPLASTIC; DRUG CARRIERS; MICELLES; PARTICLE SIZE; POLYMERS; PURINE NUCLEOSIDES;

EID: 0031722638     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(98)00054-6     Document Type: Article

References (34)

1. M. Yokoyama, S. Inoue, K. Kataoka, et al., Molecular design for missile drug: synthesis of adriamycin conjugated with IgG using poly(ethylene glycol)-poly(aspartic acid) block copolymer as intermediate carrier, Makromol. Chem. 190 (1989) 2041-2054.
2. A.V. Kabanov, V.P. Chekhonin, V.Y. Alakhov, et al., The neuroleptic activity of haloperidol increases after its solubilization in surfactant micelles: micelles as microcontainers for drug targeting, FEBS Lett. 2 (1989) 343-345.
3. M. Yokoyarna, Block copolymers as drug carriers, Crit. Rev. Therapeutic Drug Carrier Systems 9 (1992) 213-248.
4. K. Kataoka, G.S. Kwon, M. Yokoyama, Block copolymer micelles as vehicles for drug delivery, J. Control. Release 24 (1993) 119-132.
5. M. Yokoyama, Site specific drug delivery using polymeric carriers, in: I. Karube, R. Kuroda (Eds.), Advances in Polymeric Systems for Drug Delivery, Gordon and Breach Science Publishers, Yverdon, Switzerland, 1994, pp. 24-66.
6. G.S. Kwon, K. Kataoka, Block copolymer micelles as long-circulating drug vehicles, Adv. Drug Delivery Rev. 16 (1995) 295-309.
7. G.S. Kwon, T. Okano, Polymeric micelles as new drug carriers, Adv. Drug Delivery Rev. 21 (1996) 107-116.
8. M. Yokoyama, G.S. Kwon, T. Okano, et al., Preparation of micelle-forming polymer-drug conjugates, Bioconjugate Chem. 3 (1992) 295-301.
9. M. Yokoyama, T. Okano, Y Sakurai, et al., Improved synthesis of adriamycin-conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped adriamycin, J. Control. Release 32 (1994) 269-277.
10. G.S. Kwon, M. Naito, K. Kataoka, et al., Block copolymer micelles as vehicles for hydrophobic drugs, Coll. Surf. B: Biointerfaces 2 (1994) 429-434.
11. G.S. Kwon, M. Naito, M. Yokoyama, et al., Physical entrapment of adriamycin in block copolymer micelles, Pharm. Res. 12 (1995) 192-195.
12. S.B. La, T. Okano, K. Kataoka, Preparation an characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(β-benzyl L-aspartate) block copolymer micelles, J. Pharm. Sci. 85 (1996) 85-90.
13. M. Yokoyama, T. Okano, Y. Sakurai, et al., Introduction of Cisplatin into Polymeric Micelle, J. Control. Release 39 (1996) 351-356.
14. K. Kataoka, H. Togawa, A. Harada, et al., Spontaneous formation of polyion complex with narrow distribution from antisense oligonucleotide and cationic block copolymer in physiological saline, Macromolecules 29 (1996) 8556-8557.
15. S Katayose, K. Kataoka, Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer, Bioconjugate Chem., 8 (1997) in press.
16. L.W. Seymour, R. Duncan, J. Strohalm, et al., Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats, J. Biomed. Mater. Res. 21 (1987) 1341-1358.
17. A. Gabizon, D.C. Price, J. Huberty, et al., Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: Biodistribution and imaging studies, Cancer Res. 50 (1990) 6371-6378.
18. M.C. Woodle, D.D. Lasic, Sterically stabilized liposomes, Biochim. Biophys. Acta 1113 (1992) 171-199.
19. D.C. Litzinger, A.M.J. Buiting, N. van Rooijen, et al., Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes, Biochim. Biophys. Acta 1190 (1994) 99-107.
20. M. Yokoyama, G.S. Kwon, T. Okano, et al., Composition-dependent in vivo antitumor activity of adriamycin-conjugated polymeric micelle against murine colon adenocarcinoma, Drug Delivery 1 (1993) 9-11.
21. M. Yokoyama, T. Okano, Y. Sakurai, et al., Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood, Cancer Res. 51 (1991) 3229-3236.
22. M. Yokoyama, T. Okano, Y. Sakurai, et al., Polymeric micelle for anticancer drug delivery, Bioact. Mater. 23 (1996) 97-98.
23. G.S. Kwon, S. Suwa, M. Yokoyama, et al., Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer-adriamycin conjugates, J. Control. Release 29 (1994) 17-23.
24. Y. Matsumura, H. Maeda, A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46 (1986) 6387-6392.
25. H. Maeda, L.W. Seymour, Y. Miyamoto, Conjugates of anticancer agents and polymers: advantages of macromolecular in vivo. Bioconjugate Chem. 3 (1992) 351-362.
26. D. Patnum, J. Kopecek, Polymer conjugates with anticancer activity, Adv. Polymer Sci. 122 (1995) 55-123.
27. B. Uziely, S. Jeffers, R. Isacson, et al., Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies, J. Clin. Oncol. 13 (1995) 1777-1785.
28. P.G. Tardi, N.L. Boman, P.R. Cullis, Liposomal doxorubicin, J. Drug Targeting 4 (1996) 129-140.
29. M. Kamisnonara, H. Kawai, T. Sakai, et al., Oncol. Res. 6 (1994) 383-390.
30. M. Yokoyama, G.S. Kwon, T. Okano, et al., Preparation of micelle-forming polymer-drug conjugates, Bioconjugate Chem. 3 (1992) 295-301.
31. G.S. Kwon, M. Naito, M. Yokoyama, et al., Physical entrapment of adriamycin in AB block copolymer micelles, Pharm. Res. 12 (1995) 192-195.
32. R. Xu, M.A. Winnik, F.R. Hallett, et al., Light-scattering study of the association behavior of styrene-ethylene oxide block copolymers in aqueous solution, Macromolecules 24 (1991) 87-93.
33. D. Papahadjopoulos, T.M. Allen, A. Gabizon, et al., Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy, Proc. Natl. Acad. Sci., USA 88 (1991) 11460-11464.
34. D.C. Litzinger, A.M.J. Buiting, N. van Rooijen, et al., Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes, Biochim. Biophys. Acta 1190 (1994) 99-107.